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The use of quorum sensing inhibitors to interfere with biofilm formation and development in 
Burkholderia multivorans and Burkholderia cenocepacia. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
 
Gilles Brackmana, Ulrik Hillaertb, Serge Van Calenberghb, Hans J Nelisa, Tom Coenyeb* 
a Laboratory of Pharmaceutical Microbiology, Ghent University, Harelbekestraat 72, B-9000 
Ghent, Belgium. 
b Laboratory of Medicinal Chemistry, Ghent University, Harelbekestraat 72, B-9000 Ghent, 
Belgium. 
 
gilles.brackman@ugent.be 10 
ulrik.hillaert@ugent.be 11 
serge.vancalenbergh@ugent.be 12 
hans.nelis@ugent.be 13 
tom.coenye@ugent.be *Correspondence and reprints 14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
 
 
 
 
 
 
 
 
 
 
 
 2
Abstract: 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
Burkholderia cepacia complex strains are opportunistic pathogens, causing life-threatening 
infections in CF patients. Burkholderia cepacia complex strains are resistant to many 
antimicrobial agents and commonly produce biofilms in vitro and in vivo. This contributes to 
their virulence and makes Burkholderia infections difficult to treat. Recently, the quorum 
sensing system of Burkholderia spp. has been found to affect their biofilm forming ability, 
making it an attractive target for antimicrobial therapy. However, detailed information about 
the antibiofilm effect of these compounds is still lacking. In the present study we evaluated 
the anti-biofilm effect of several known quorum sensing inhibitors. The effect on 
Burkholderia spp. biofilm formation was examined using crystal violet, resazurin and SYTO9 
staining, confocal laser scanning microscopy as well as plating. Used in sub-inhibitory 
concentrations, several compounds interfered with biofilm formation by Burkholderia spp. 
Our results suggest that the quorum sensing inhibitors affect later stages of biofilm formation 
and detachment.  
 
Keywords: Burkholderia cepacia complex; biofilms; quorum sensing 
 
 
 
 
 
 
 
 
 
 3
1. Introduction 1 
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The Burkholderia cepacia complex (Bcc) is a group of closely related Gram-negative bacteria 
[6]. Bcc species are opportunistic pathogens causing severe infections in patients with 
immune suppression, chronic granulomatous disease and cystic fibrosis (CF) [21]. Although 
all Bcc species are found in CF patients, overall Burkholderia multivorans and Burkholderia 
cenocepacia predominate [20; 38]. Bcc species are capable of forming biofilms in vitro and in 
vivo [8], which probably plays an important role in virulence [35]. In addition, bacteria 
growing in biofilms are less susceptible to many antibacterial agents [5]. For these reasons, 
novel approaches to treat these biofilm-related infections are needed. A possible novel target 
is the bacterial communication system [37]. Bacteria monitor their population density through 
the production and sensing of small signal molecules called autoinducers [3]. This 
communication system, known as quorum sensing (QS), consists of three components: signal 
molecules, signal synthases and signal receptors. At low population density only basal 
amounts of diffusible signal molecules are produced, not provoking an effect. However, when 
the population density is sufficiently high, signal molecules will bind to a receptor and this 
signal/receptor complex will then induce or repress the transcription of QS regulated genes. 
Several N-acyl-homoserine-lactone (AHL)-dependent QS systems have been reported in 
Burkholderia species [37]. In most Bcc species, CepI catalyzes the production of two AHL’s, 
N-octanoyl-homoserine lactone (C8-HSL) (in high amounts) and N-hexanoyl-homoserine 
lactone (C6-HSL) (in lower amounts).  B. cenocepacia epidemic strains contain a second QS 
system, CciIR [2]. The major signal molecule involved in the latter is C6-HSL [22]. In some 
Burkholderia spp. a quinolone dependent QS system can also be found [42]. This type of 
communication system was previously described in Pseudomonas aeruginosa and makes use 
of hydroxy-alkylquinolines (HAQ) as signal molecules [30]. It has recently been discovered 
that HAQs produced by Burkholderia spp. predominantly contain an unsaturated aliphatic 
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side chain and are typically methylated [42]. In several Burkholderia spp., the QS system is 
presumably involved in biofilm formation [8; 14; 41]. Hence, QS inhibitors have been 
proposed as potential novel antibiofilm agents [37]. Since these QS inhibitors are typically 
used in concentrations below the minimal inhibitory concentration (MIC), it is less likely that 
they would impose a selective pressure for the development of resistance. Many studies have 
been conducted to find natural and synthetic QS inhibitors [9-10; 15-16; 18; 26; 31-32; 34; 
40; 44]. However, detailed information about the antibiofilm effect of these compounds is still 
lacking. In the present study, we examined the antibiofilm effect of several established QS 
inhibitors in B. multivorans and B. cenocepacia, the two Bcc species most often responsible 
for infections in CF patients. 
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2. Materials and Methods 1 
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2.1. QS inhibitors 
Cinnamaldehyde [26], resveratrol [43], L-canavanine [16], 4-nitropyridine N-oxide, p-
benzoquinon and indole [31], azithromycin [40], ceftazidime hydrate and tobramycin [10], 
farnesol [9], (-)- epigallocatechin gallate and (+)- catechin hydrate [15], 2-amino-4-
chlorobenzoic acid (4CABA) , 2-amino-6-chlorobenzoic acid (6CABA) and 2-amino-6-
fluorobenzoic acid (6FABA) [18], curcumin [34], baicalein, baicalin hydrate and esculin 
hydrate [44] were purchased from Sigma-Aldrich (Bornem, Belgium). Esculetin [44] and 
N’3-(2-thienylcarbonyl)-4-bromo-1,5-dimethyl-1H-pyrazole-3-carbohydrazide (“compound 
1”) [32] were purchased from Acros Organics (Geel, Belgium). N’-(6-tert-butyl-2,3-dihydro-
2-methylpyridazin-4-yl)-5-chlorothiophene-2-carbohydrazide (“compound 3”) was 
synthesized as previously described [32]. All compounds were diluted in 0.5 % DMSO. A 
control solution (CS) containing only DMSO was made in MilliQ water. The stock solutions 
were stored at -20°C.  
 
2.2. Strains and culture conditions 
Chromobacterium violaceum CV026 [24] and Escherichia coli JB523 [1] were grown 
aerobically on Luria Bertani (LB) agar (BD, Sparks, MD, USA) containing 20 µg/ml 
kanamycin or 100 µg/ml tetracycline, respectively. For E. coli JB523 the medium contained 4 
% NaCl. The QS-inhibition (QSI) selector P. aeruginosa QSIS2 [31] was cultured aerobically 
in ABT minimal medium (AB medium, containing 2.5 mg/l of thiamine) supplemented with 
0.5 % glucose, 0.5 % casamino acids and 80 µg/ml gentamycin. B. cenocepacia strains 
LMG18828 and LMG16656 (containing a CepI/R and CciI/R QS system) and B. multivorans 
strains LMG13010 and LMG17588 (containing the CepI/R QS system) were cultured 
aerobically on Tryptone Soya Agar (Oxoid, Hampshire, UK) or in Scientific Cystic Fibrosis 
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Medium (SCFM) [28]. All strains were grown at 37°C, with the exception of E. coli JB523 
(30°C) and C. violaceum CV026 (27°C).  
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2.3. Determination of the minimal inhibitory concentration (MIC) 
MIC’s were determined using a modified microdilution assay in 96-well microtiter plates 
(MTP), using the media mentioned above [13]. The inoculum, prepared from a 24 h old 
culture contained approximately 106 CFU/ml in double concentrated medium. The 
compounds stock solutions were diluted in MilliQ water in a series of twelve 2-fold dilutions 
in the wells of a 96 well microtiter plate (MTP) (TPP, Trasadingen, Switzerland). Two rows 
of dilutions were made for each compound and the volume of each sample was 100 μl. To the 
wells of one row of each compound, 100 μl inoculum was added. To the other row, 100 μl 
double concentrated medium was added as a negative control. The plates were incubated for 
24 h and the absorbance at 590 nm was measured using a Victor Wallac² multilabel counter 
(Perkin Elmer Life and Analytical Sciences, Boston, MA, USA). The absorbances of the 
negative controls were subtracted from those of the corresponding inoculated wells to give net 
absorbances. The plates were incubated for 24 h. For all further experiments, a single sub-
MIC concentration was selected for each compound, being the highest concentration that did 
not affect growth in any of the strains included in the present study. 
 
2.4. QS inhibition (QSI) assays 
C. violaceum CV026 is a mini-Tn5 mutant of ATCC 31532 allowing the detection of 
violacein in response to C6-HSL QS activation [24]. The C. violaceum CV026 QSI assay was 
conducted as previously described [23]. In brief, an overnight culture of the reporter strain 
was diluted in fresh sterile LB medium to an OD590nm = 0.1 and 100 µl of this cell suspension 
was added to the wells of a 96-well MTP (Perkin Elmer). Kanamycin was added to a final 
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concentration of 20 µg/ml. Activation of QS by AHL was tested by addition of C6-HSL (2.5 
µM) (Sigma). Sterile MilliQ water served as a negative control. To study inhibition using C. 
violaceum CV026, test compounds were added in selected sub-MIC concentrations. The MTP 
was then incubated for 48 h at 27°C to allow induction of violacein formation. The plates 
were then dried at 60°C until all medium had evaporated (6 h). The violacein was 
resolubilized by adding 100 μl of DMSO to each well and the plates incubated on a lab shaker 
for two hours. The absorbance was measured at 590 nm using a Victor Wallac² multilabel 
counter (Perkin Elmer).  E. coli JB523 contains the pJBA130 plasmid (expressing the green 
fluorescent protein GFP in response to C6-HSL) [1]. The E. coli JB523 QSI assay was carried 
out in a 96-well MTP. In brief, an overnight culture of the reporter strain was diluted in fresh 
sterile LB medium containing 4 % (w/v) NaCl to an OD590nm = 0.1 and 100 µl of this cell 
suspension was added to the wells of a black 96-well MTP (Perkin Elmer). Tetracycline was 
added to a final concentration of 100 µg/ml. Activation of QS by AHL was tested by addition 
of C6-HSL (5 µM) (Sigma). Sterile MilliQ water served as a negative control. To study 
inhibition using E. coli JB523, test compounds were added in selected sub-MIC 
concentrations. The MTP was then incubated for 24 h at 30°C and fluorescence from GFP 
expression was measured at λex 475 nm and λem 515 nm using a Victor Wallac² multilabel 
counter (Perkin Elmer). The QSI selector strain QSIS2, previously developed by Rasmussen 
et al. (2005) is a P. aeruginosa lasI rhlI double mutant harbouring pLasB-SacB1 encoding an 
AHL-induced killing system. A QSIS2 QSI assay was developed in microtiter format based 
on the plate assay described by Rasmussen et al. (2005). An overnight culture of the reporter 
strain was diluted in fresh sterile ABT medium to an OD590nm= 0.1 and 50 µl of this cell 
suspension was added to the wells of a 96-well MTP. Fifty µl LB supplemented with sucrose 
(56 mg/ml) was added to each well. Gentamycin was added in a concentration of 80 µg/ml. 
Activation of QS by AHL’s was tested by addition of 3-oxo-C12-HSL and C4-HSL (Sigma) 
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(200 nM each) to the wells. Sterile MilliQ water served as a negative control. To study 
inhibition using QSIS2, test compounds were added in selected concentrations. The MTP was 
then incubated for 10 h at 37°C and the absorbance was measured at 450 nm using a Victor 
Wallac² multilabel counter. The difference in growth of the negative control (without addition 
of compound and without AHL) and that of the positive control (without addition of 
compound and with AHL) was set at 100 %. Each compound was tested six times in each 
assay and each assay was repeated at least six times (n ≥ 36). 
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2.5. Biofilm formation in 96-well MTP 
Biofilms were formed as previously described [4]. In brief, the Bcc strains were grown 
overnight in SCFM, centrifuged, resuspendend in double concentrated SCFM (2xSCFM) and 
diluted to an OD590nm = 0.1 in 2xSCFM. Fifty µl of the diluted bacterial suspension was 
transferred to the wells of a round-bottomed 96-well microtiter plate (TPP). Negative controls 
received 50 µl of CS. Positive controls received 50 µl of the test compound. Bacteria were 
allowed to adhere and grow without agitation for 4 h at 37°C. After 4 h, plates were emptied 
and washed with sterile physiological saline (PS). After this washing step, negative control 
wells were filled with 50 µL 2xSCFM and 50 µl CS. Other wells were filled with 50 µl 
2xSCFM and 50 µl compound solution and the plate was incubated for 24 h at 37°C. The 
biomass was quantified by crystal violet (CV) staining, as described previously [29]. In brief, 
plates were rinsed with sterile PS, biofilms were fixed by adding 100 µl 99 % methanol for 15 
min, after which the methanol was removed and plates were air-dried. Biofilms were then 
stained with 100 µl CV (Pro-lab Diagnostics, Richmond Hill, ON, Canada). After 20 min, CV 
was removed and wells were filled with 150 µl 33 % acetic acid (Sigma-Aldrich). The 
absorbance was measured at 590 nm using a Wallac Victor2 multilabel counter. 
Quantification of the number of metabolically active (i.e. living) cells in the biofilm was done 
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using resazurin assay (CellTiter-Blue CTB) [29]. In brief, wells were rinsed after 24 h biofilm 
formation and 100 µl PS was added, followed by addition of 20 µl CellTiter-Blue (CTB) 
(Promega, Leiden, The Netherlands) solution. After 60 min, fluorescent (excitation and 
emission filters of 486 nm and 535 nm) was measured using a Wallac Victor2 multilabel 
counter. Each compound was tested six times in each assay and each assay was repeated at 
least four times (n ≥ 24). 
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2.6. Biofilm formation on silicone disks and evaluation of the effect on biofilms 
For the quantification of the number of adhered cells and number of detached cells, B. 
cenocepacia LMG16656 was allowed to form biofilms on silicone disks (Q7-4735; Dow 
Corning) in a 24-well plate in the presence and absence of test compounds. In brief, 500 µL of 
the diluted bacterial suspension was transferred to the wells of a 24-well plate (TPP, 
Trasadingen, Switzerland) containing a sterile silicone disk. Subsequently, 500 µl of the test 
compound was added. To control wells we added 500 µl CS. Bacteria were allowed to adhere 
and grow without agitation for 4 h at 37°C. After 4 h, the growth medium was removed, the 
disks were rinsed with 0.9 % (w/v) NaCl and 500 µl 2xSCFM and 500 µl test compound was 
added. The plate was further incubated for 24 h at 37°C. The number of culturable sessile 
cells and the total number of cells present on the silicone disks were determined after 4 h and 
24 h by plating as previously described [7]. In brief, each disk was transferred to 10 ml 0.9 % 
(w/v) NaCl. The tubes were subjected three times to 30 s of sonication (Branson 3510, 
42 kHz, 100 W; Branson Ultrasonics Corp., Danbury, CT) and 30 s of vortex mixing to 
remove the biofilm cells from the disks. Using this procedure, all cells are removed from the 
disks and clumps of cells were broken apart (data not shown). The number of sessile 
Burkholderia cenocepacia LMG16656 cells was quantified by plating on TSA. All plates 
were incubated at 37°C for 24 h and the number of CFU per disk was calculated by counting 
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colonies on the plates. To quantify the number of bacteria released from the biofilms on the 
silicone disks and the number of cells adhering to the disk, the number of cells in the medium 
and the rinsing solution after 4 and 24 h was determined by plating. Each compound was 
tested on three disks in each assay and each assay was repeated at least three times (n ≥ 9). 
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2.7. Confocal laser scanning microscopy (CLSM)  
Biofilms of Burkholderia cenocepacia LMG16656 were formed on silicone disks as 
described above. The effect of “compound 3” on biofilm formation was evaluated after 4 h of 
adhesion and after 24 h of biofilm formation. For CLSM, the biofilm-covered disks were 
placed in the wells of a 24-well plate (Greiner bio-one, Longwood, FL, USA) and covered 
with 1 ml of PS containing 3 µl of SYTO9. The plates were incubated for 15 min at room 
temperature and the biofilm was visualised with a Nikon C1 confocal laser scanning module 
attached to a motorized Nikon TE2000-E inverted microscope (Nikon Benelux, Brussels, 
Belgium) equipped with a Plan Apo VC 60x 1.4 NA oil immersion objective and suitable 
optical elements to obtain fluorescent and differential interference contrast (DIC) transmission 
images. SYTO9 was excited with the Argon ion 488 nm laser line and emission light was 
collected using a 500-530 nm band pass filter and Z-stacks were recorded. Tests were 
performed on at least two disks for each situation and representative images are shown. 
 
2.8. Statistics  
The normal distribution of the data was checked using the Shapiro-Wilk test. Normally 
distributed data were analyzed using an Independent samples T-tests. Non-normally 
distributed data were analyzed using the Mann-Whitney U test. Statistics were performed 
using the SPSS software, version 15.0 (SPSS, Chicago, IL, USA). 
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3. Results 1 
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3.1. AHL-QSI 
The MICs for all compounds were determined (data not shown). In all further experiments, 
the compounds were used in concentrations that were below this MIC. In order to confirm 
QSI, we retested the 22 QS inhibitors in the three QSI detection systems (Table 1). Maximum 
levels of inhibition in the three assays were found for the following compounds: esculetin (55 
± 23 %) (C. violaceum CV026 QSI assay), esculetin (50 ± 20 %), baicalin hydrate (50 ± 7 %) 
and p-benzoquinon (41 ± 17 %) (E. coli JB523 QSI assay), esculetin (67 ± 2 %), “compound 
3” (58 ± 4 %), “compound 1” (38 ± 17 %) and esculin hydrate (29 ± 8 %) (P. aeruginosa 
QSIS2 QSI assay).  
 
3.2. Quantification of the effect of QSI on biofilm formation in 96-well MTPs 
There was a significant decrease in biofilm formation relative to the control when the 
different strains were grown in the presence of various QS inhibitory compounds (Table 2). 
The use of “compound 3” (500 µM), baicalin hydrate (500 µM) and farnesol (2500 µM) 
resulted in a reduction of biofilm biomass in all strains tested, as quantified by CV staining. 
The biofilm biomass in any of the four strains was not reduced by 2-amino-6-chlorobenzoic 
acid, 2-amino-4-chlorobenzoic acid and (+)- catechin. The 16 other compounds affected the 
biofilm biomass in at least one of the strains tested. Using CTB-staining, nine out of the 22 
compounds were found to reduce the number of metabolically active biofilm cells in all four 
strains tested. In addition, all 22 compounds significantly affected the number of 
metabolically active cells in at least one strain. In contrast to what was observed for the other 
compounds, the use of tobramycin (2 µM) resulted in a moderate but significant increase in 
biomass and numbers of metabolically active cells in B. multivorans LMG17588 and B. 
cenocepacia LMG18828.  
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3.3. Effect of QS inhibitors on sessile cell numbers and detachment 
After 4 h, the number of cells present on the disks and in the growth medium did not 
significantly differ between the treated and untreated disks (Table 3). However, significantly 
more cells were removed during the rinsing step after 4 h from the disks treated with 
azithromycin, cinnamaldehyde, farnesol and indole. After 24 h, significantly fewer cells were 
present on the silicone disks treated with QS inhibitory compounds compared to the control 
(Table 3). In contrast, after 24 h a significantly higher number of colony forming units (CFU) 
was present in the growth medium of the biofilms treated with azithromycin, ceftazidime, 
“compound 3”, farnesol and indole compared to the growth medium of the control biofilm 
(Table 3). The number of cells removed during the final rinsing step was significantly higher 
for the biofilms treated with azithromycin, cinnamaldehyde and farnesol in comparison to the 
control (Table 3). Total numbers of CFU (both sessile and planktonic) were not significantly 
different after 4 h and 24 h of growth. 
 
3.4. Confocal scanning laser microscopy 
Consistent with the results obtained by plating, no differences between the treated biofilm and 
the untreated control were observed after 4 h of adhesion (Fig 1A). However, after 24 h 
CLSM revealed clear differences in B. cenocepacia LMG16656 biofilm structure between 
biofilms treated with “compound 3” (500 µM) and the untreated control (Fig 1B), as the 
former biofilm was less structured and contained less cells. 
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4. Discussion 1 
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4.1. AHL-QSI  
Since the compounds used in this study were previously reported to affect QS in at least one 
QS reporter, we expected that they would exhibit an effect in at least one of the QSI detection 
systems used in this study. However, we often observed only a moderate QS-inhibitory effect. 
This may be due to the lower concentrations used in the present study in order to perform  
experiments with sub-MIC concentrations for all test strains. A second possible explanation 
concerns the mechanism by which the compounds affect the QS system. For example, 
azithromycin reportedly affects several QS regulated phenotypes in P. aeruginosa [12; 40] by 
decreasing LasI and RhlI gene expression. However, since the biosensor strains used in the 
present study are unable to produce signal molecules themselves, the latter were externally 
added so that no effect at the level of the biosynthesis of signal molecules can be observed. 
Recently, Skindersoe et al. (2008) found that several antibiotics, including azithromycin and 
ceftazidime influenced QS in P. aeruginosa by changing membrane permeability, thereby 
influencing the uptake of signal molecules. However, this effect could not be confirmed in the 
present study. A third explanation for the inability of some compounds to interfere with QS in 
these detection systems could lie in the specificity of the detection system and/or of the 
compound. For example, cinnamaldehyde seems to have no effect on P. aeruginosa QS, using 
the QSIS2 detection system, while moderate effects were observed in the other two QS 
detection systems. Niu et al. (2006) previously showed that cinnamaldehyde interfered with 
the binding of short chain signal molecules (like C6-HSL used as a signal molecule in E. coli 
JB523 and C. violaceum CV026 detection system), but that it failed to substantially reduce the 
binding of longer chain signal molecules like 3-oxo-C12-HSL. In addition, farnesol and 
various halogenated benzoic acids were previously found to influence PQS related QS 
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systems in P. aeruginosa, but the systems used here only detect a direct effect on the 
interaction between AHL signal molecules and the AHL-receptor. However, it should be 
noted that 2-amino-6-chlorobenzoic acid affect QS in the E. coli JB523 QSI detection system 
and that 2-amino-6-fluorobenzoic acid inhibited QS in both the E. coli JB523 and C. 
violaceum CV026 QSI systems.  
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4.2. Effect of QS inhibitors on biofilms 
Results from several reports suggest that targeting QS could be a new strategy to fight biofilm 
infections [25]. However, only few QS inhibitory compounds have been evaluated in sub-
MIC concentrations for their anti-biofilm effect against Bcc biofilms. Several QS inhibiting 
polyphenols and “compound 3” influenced biofilm formation of B. cenocepacia H111 [15; 
32]. For the other QS inhibitory compounds the effect on biofilms has not been evaluated at 
all or only on non-Bcc species [12; 17; 34; 39; 44]. For this reason we wanted to explore 
whether QS inhibitory compounds (when used in sub-MIC concentrations) could affect Bcc 
biofilm formation in this study. To this end we selected 22 established QS inhibitory 
compounds and evaluated their antibiofilm effect against the two Bcc species most often 
involved in CF infections. As can be seen in Table 2, 21 out of 22 components tested resulted 
in a reduction in biofilm formation in at least one strain. Interestingly, several compounds 
were shown to affect biofilm formation in all the strains tested, while others did so in one or a 
few strains only. Most of the compounds reduced the total biofilm biomass (as quantified by 
CV staining), as well as the number of metabolically active cells (as quantified by CTB 
staining). However, some compounds that yielded in a reduction of the number of living cells 
failed to reduce the total biomass (e.g. (+)-catechin). The use of tobramycin (2 µM) resulted 
in an increase in biofilm biomass and in the number of metabolically active cells in two 
strains, i.e. B. multivorans LMG17588 and B. cenocepacia LMG18828. This increase was 
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previously also observed for P. aeruginosa [11]. Since all compounds were tested in sub-MIC 
concentrations, the reduction in metabolically active cells can not be explained by lethal 
effects. Indeed, when using SYTO9 (a DNA-binding dye that stains both living and dead 
cells) a reduction in fluorescence was observed in treated biofilms. As the fluorescence of 
dead cells is approximately equal to that of living cells, this reduction suggests that treatment 
with QS inhibitors results in lower cell numbers through reduced attachment and/or increased 
detachment. This was investigated by determining the number of CFU present on the disks 
(after 4 and 24 h of growth), by determining the number of CFU present in the surrounding 
growth medium and in the rinsing solution (after 4 h and 24 h) and by visualizing the biofilms 
with CSLM (after 4 and 24 h of growth). Significantly lower amounts of cells were indeed 
present on the disks treated with the compound after 24 h, while no differences were observed 
after 4 h. In addition, more detached cells were found in the growth medium and rinsing 
solution after 24 h. These data suggest that the QS inhibitors do not exert their effect during 
initial stages of attachment, but rather promote detachment at later stages. This is in 
agreement with previously published data. Huber et al. (2001) found no difference in initial 
attachment for a B. cenocepacia H111 CepIR mutant compared to the wild type but suggested 
that a functional QS system was required for maturation of the biofilm. In addition, 
biosurfactant production, which was previously found to be regulated by QS in several 
bacteria [19; 27] possibly influences detachment from surfaces [33]. However, whether these 
QS inhibitory compounds indeed exert their effect through a change in biosurfactant 
production in Bcc biofilms remains to be determined.  
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Whether these compounds, either alone or in combination with conventional antimicrobial 
agents, will ever be useful as anti-biofilm agents remains to be determined in future studies. 
However, there are indications that there may be a role for these compounds, even though 
their anti-biofilm effect is only moderate. For example, Tomlin et al. [41] showed that, despite 
 16
the fact that the changes observed with their biofilm model were not biologically relevant, 
disrupting the QS system made sessile B. cenocepacia cells more susceptible to antibiotics. 
This supports the idea that a decrease in the overall structural stability of the biofilm, although 
it may not be biologically relevant at first sight, may allow for more efficacious removal of 
bacteria by other means.  
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Figure 1: Representative confocal images of B. cenocepacia LMG16656 biofilms treated with 
“compound 3” (500 µM) or an untreated control. Biofilms were stained using SYTO9 and 
CLSM pictures were taken after 4 h adhesion (A) and after 24 h of biofilm growth (B) (at 
both time points following the rinsing step). The larger central plots are fluorescence 
projections. Shown in the right and lower frames are vertical sections through the biofilms. 
The scale bar represents 10 µm. 
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Table 1 : QS inhibitory effects of several QS inhibitors in the three QSI detection systems. QSI is expressed as % inhibition (± standard deviation). 
NS: not significant (p > 0.05; Independent Sample T-test). 
1 
2 
 
    % inhibition (± SD) 
Compound  Conc (µM)  C. violaceum  CV026  
E. coli  
JB523  
P. aeruginosa 
QSIS2 
     
4CABA  50  NS  NS  NS 
6CABA  50  NS  22 ± 23  NS 
6FABA  50  11 ± 11  32 ± 22  NS 
Azithromycin  2  NS  22 ± 12  NS 
Baicaleïn  1  15 ± 12  31 ± 28  NS 
Baicalin hydrate  100  25 ± 2  50 ± 7  7 ± 11 
p-Benzoquinon  20  11 ± 12  41 ± 17  15 ± 8 
L-canavanine  62.5  14 ± 4  9 ± 3  NS 
(+)- Catechin  312  11 ± 3  8 ± 3  NS 
Ceftazidime hydrate  0.075  9 ± 5  11 ± 15  NS 
Cinnamaldehyde  100  16 ± 15  15 ± 7  NS 
“Compound 1”  500  29 ± 13  22 ± 18  38 ± 17 
“Compound 3”  500  9 ± 4  NS  58 ± 4 
Curcumin  500  18 ± 12  37 ± 14  NS 
(-)- Epigallocatechin gallate  50  16 ± 12  26 ± 4  NS 
Esculetin  500  55 ± 23  50 ± 20  67 ± 2 
Esculin hydrate  500  25 ± 13  19 ± 13  29 ± 8 
Farnesol  500  NS  NS  NS 
Indole  312  13 ± 4  19 ± 14  14 ± 14 
4-nitropyridine oxide  10  NS  NS  21 ± 4 
Resveratrol  25  14 ± 3  19 ± 14  NS 
Tobramycin  0.5  14 ± 1  16 ± 4  NS 
            
 3 
4 
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Table 2: The effect of QSI on biofilm biomass (CV) and amount of metabolically active cells (CTB) after 24 h of biofilm formation. The effect is 
expressed as % inhibition (± SD). NS: not significant (p > 0.05; Independent Sample T-test). 
1 
2 
 29
 
percentage inhibition CV signal (± SD)  percentage inhibition CTB signal (± SD) 
B. multivorans B. cenocepacia  B. multivorans B. cenocepacia Compound (conc) 
LMG13010 LMG17588 LMG18828 LMG16656  LMG13010 LMG17588 LMG18828 LMG16656
          
4CABA (50 µM) NS NS NS NS  NS NS NS 25 ± 2  
6CABA (50 µM) NS NS NS NS  NS NS NS 19 ± 9  
6FABA (50 µM) NS 25 ± 8  NS NS  NS 28 ± 13  NS 29 ± 4  
Azithromycin (2 µM) NS NS NS 15 ± 16   25 ± 10  55 ± 3 32 ± 5  40 ± 11 
Baicalein (1 µM) NS 13 ± 7  NS NS   NS 28 ± 8  NS 16 ± 3 
Bacalin hydrate  (100 µM) 48 ± 7  37 ± 9  62 ± 2  11 ± 19   46 ± 5 28 ± 12  54 ± 8 16 ± 4 
p-benzoquinon (100 µM) NS NS 21 ± 8  31 ± 36   NS NS 18 ± 6  18 ± 24 
L-Canavanine (20 µM) NS 19 ± 7  14 ± 8  43 ± 25   11 ± 13  29 ± 9  10 ± 4  26 ± 20 
(+)- Catechin (1000 µM) NS NS NS NS  26 ± 14  35 ± 11  30 ± 6  48 ± 17 
Ceftazidime hydrate  (1 µM) 8 ± 12  29 ± 5  NS 41 ± 21   28 ± 11 54 ± 12 37 ± 9  22 ± 15 
Cinnamaldehyde (250 µM) NS 11 ± 10 12 ± 15  31 ± 29   NS 11 ± 12  22 ± 4  12 ± 16 
“Compound 1” (500µM) 17 ± 24  39 ± 9  NS 53 ± 18   20 ± 9  22 ± 8  NS 25 ± 14  
“Compound 3” (500 µM) 37 ±10  26 ± 14  19 ± 10  54 ± 8   22 ± 9  35 ± 10  NS 45 ± 9  
Curcumin (500 µM) 23 ± 12  24 ± 6  NS NS  21 ± 10  14 ± 4  NS NS 
(-)- Epigallocatechin gallate (0.4 µM) NS 16 ± 6  24 ± 9  10 ± 14   NS 40 ± 7  20 ± 15  26 ± 8  
Esculetin (500 µM) 25 ± 10  26 ± 13  NS 10 ± 15   19 ± 15  11 ± 6  11 ± 6 10 ± 5 
Esculin hydrate (500 µM) 22 ± 13  46 ± 4  NS 9 ± 13   17 ± 10  9 ± 9  NS NS 
Farnesol (2500 µM) 42 ± 10  38 ± 5  22 ± 10  50 ± 13   26 ± 8  41 ± 14  41 ± 3  58 ± 11 
Indole (312 µM) NS NS NS 23 ± 22   12 ± 8  19 ± 13  28 ± 5  19 ± 11 
4-nitropyridine N-oxide (8 µM) NS 14 ± 6  NS 26 ± 22   NS 27 ± 6  NS 21 ± 3  
Resveratrol (25 µM) NS 12 ± 8  9 ± 13  38 ± 18   17 ± 17  25 ± 11  25 ± 3  30 ± 16 
Tobramycin (2 µM) NS -16 ± 9  -15 ± 11  NS  NS -12 ± 18  -9 ± 6 NS 
 1 
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Table 3: Numbers of cells present after 4 h and 24 h in the growth medium (M), rinsing solution (RS) and on the disks as well as total cell 
numbers (TCN) present in the wells. *: p < 0.05 (Mann-Withney U) 
 
 
 Numbers of cells present after 4 h 
Compound  M (CFU/ml) (x108)(±SD) RS (CFU/ml) (x108) (±SD) Disks (CFU/ Disk) (x108)(±SD) 
TCN (CFU/well) 
(x108)(±SD) 
CTRL  1.01 ± 0.17 0.48 ± 0.10 1.34 ± 0.37 2.83 ± 0.42 
Azithromycin (2µM)  0.89 ± 0.28 0.71 ± 0.21* 1.15 ± 0.37 2.76 ± 0.44 
Ceftazidime hydrate (1 µM)  0.99 ± 0.48 0.54 ± 0.23 1.28 ± 0.62 2.81 ± 0.78 
Cinnamaldehyde (250 µM)  1.04 ± 0.05 0.74 ± 0.13* 1.12 ± 0.37 2.97 ± 0.41 
“Compound 3” (500 µM)  1.00 ± 0.04 0.52 ± 0.13 1.14 ± 0.14 2.65 ± 0.24 
Farnesol (2500 µM)  0.94 ± 0.06 0.80 ± 0.27* 1.15 ± 0.45 3.18 ± 0.53 
Indole (312 µM)  0.82 ± 0.49 0.71 ± 0.13* 1.34 ± 0.11 2.96 ± 0.60 
      
  Numbers of cells present after 24 h 
Compound  M (CFU/ml) (x108)( ±SD) RS (CFU/ml) (x108)( (±SD) Disks (CFU/ Disk) (x108)(±SD) 
TCN (CFU/well) 
(x108)(±SD) 
CTRL  1.36 ± 0.12 0.92 ± 0.24 1.99 ± 0.29 4.27 ± 0.40 
Azithromycin (2µM)  2.33 ± 0.33* 1.63 ± 0.55* 0.71 ± 0.12* 4.68 ± 0.66 
Ceftazidime hydrate (1 µM)  2.15 ± 0.07* 0.95 ± 0.07 1.30 ± 0.04* 4.40 ± 0.11 
Cinnamaldehyde (250 µM)  1.84 ± 0.25* 1.58 ± 0.08* 0.89 ± 0.14* 4.30 ± 0.30 
“Compound 3” (500 µM)  2.46 ± 0.34* 1.18 ± 0.23 0.85 ± 0.19* 4.49 ± 0.46 
Farnesol (2500 µM)  2.44 ± 0.79* 1.29 ± 0.10* 0.49 ± 0.31* 4.22 ± 0.85 
Indole (312 µM)  1.79 ± 0.01* 0.96 ± 0.09 1.32 ± 0.11* 4.15 ± 0.15 
      3 
4 
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Figure 1:  
 
